Autologous Peripheral Blood Mononuclear Cell Recognition of Autologous Proliferating Tumor Cells in the Context of a Patient-Specific Vaccine Trial

Metastatic melanoma patients who were treated with patient-specific vaccines consisting of dendritic cells loaded with autologous tumor cells had a 5-year survival of over 50%. Enzyme-linked immunospot (ELISPOT) has been used to detect antigen reactive T cells as a means of determining immune respon...

Descripción completa

Detalles Bibliográficos
Autores principales: Cornforth, A. N., Lee, G., Dillman, R. O.
Formato: Texto
Lenguaje:English
Publicado: Hindawi Publishing Corporation 2011
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3085493/
https://www.ncbi.nlm.nih.gov/pubmed/21541189
http://dx.doi.org/10.1155/2011/635850

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3085493/
https://www.ncbi.nlm.nih.gov/pubmed/21541189
http://dx.doi.org/10.1155/2011/635850

Ejemplares similares